Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Wielenga JJ"'
Autor:
van Buuren, Henk, Wielenga, JJ (Jenne)
Publikováno v:
Digestive Diseases & Sciences, 47(9), 2134-2136. Springer New York
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::a501a76e19627beebcf225f2ce7a77f3
https://pure.eur.nl/en/publications/41d2115c-0e24-4d80-87ae-c208e05ff0af
https://pure.eur.nl/en/publications/41d2115c-0e24-4d80-87ae-c208e05ff0af
Autor:
Heule, Ed, Heide, R, Wielenga, JJ (Jenne), Budel, LM (Leo), Langerak, Ton, van Joost, T (Theo)
Publikováno v:
Nederlands Tijdschrift voor Dermatologie & Venereologie, 9, 199-203. DCHG Partners in Mediscne Communicatie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::43bc6eb7a6bd1c3780c1d6facb38794f
https://pure.eur.nl/en/publications/9cf5f0c7-0597-409a-8c14-923dda5c891b
https://pure.eur.nl/en/publications/9cf5f0c7-0597-409a-8c14-923dda5c891b
Autor:
Nouwen, Jan, Belkum, Alex, de Marie, S (Siem), Sluijs, J, Wielenga, JJ (Jenne), Kluytmans, JAJW (Jan), Verbrugh, Henri
Publikováno v:
Journal of Clinical Microbiology, 36(9), 2696-2702. American Society for Microbiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::ad5d156028a10c5b3c7a20af1538e535
https://pure.eur.nl/en/publications/434520ae-2d57-4d6e-942e-4557d46cb9f8
https://pure.eur.nl/en/publications/434520ae-2d57-4d6e-942e-4557d46cb9f8
Autor:
Rozemuller, H (Henk), Terpstra, WE, Rombouts, Elwin, Lawler, M, Byrne, C, FitzGerald, DJP, Kreitman, RJ, Wielenga, JJ (Jenne), Löwenberg, Bob, Touw, Ivo, Hagenbeek, A (Anton), Martens, ACM (Anton)
Publikováno v:
Leukemia, 12, 1962-1970. Nature Publishing Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::6cfe1297ec980c2f876afa85aad587fa
https://pure.eur.nl/en/publications/77722191-9824-49e8-8ad6-4f34ce3a6862
https://pure.eur.nl/en/publications/77722191-9824-49e8-8ad6-4f34ce3a6862
Autor:
Lowenberg, B, Boogaerts, MA, Daenen, SMGJ, Verhoef, GEG, Hagenbeek, A, Vellenga, E, Ossenkoppele, GJ, Huijgens, PC, Verdonck, LF, vanderLelie, J, Wielenga, JJ, Gmur, J, Gratwohl, A, Hess, U, Fey, MF, vanPutten, WLJ
Publikováno v:
Journal of Clinical Oncology, 15(12), 3496-3506. AMER SOC CLINICAL ONCOLOGY
Purpose: The hematopoietic growth factors (HGFs) introduced into induction chemotherapy (CT) of acute myeloid leukemia (AML) might be of benefit to treatment outcome by at least two mechanisms. HGFs given on days simultaneously with CT might sensitiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e708b41fc2eea13de27b75388dbcb384
https://research.rug.nl/en/publications/c8032e18-17b5-440d-bf31-9a408cc453d4
https://research.rug.nl/en/publications/c8032e18-17b5-440d-bf31-9a408cc453d4
Autor:
Terpstra, WE, Rozemuller, H (Henk), Breems, DA, Rombouts, Elwin, Prins, A (Ad), FitzGerald, DJP, Kreitman, RJ, Wielenga, JJ (Jenne), Ploemacher, Rob, Löwenberg, Bob, Hagenbeek, A (Anton), Martens, ACM (Anton)
Publikováno v:
Blood, 90(9), 3735-3742. American Society of Hematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::26558f271ae1cea6533aa312847e0f2d
https://pure.eur.nl/en/publications/4faa317f-96fd-474a-96a6-4ba1a5a8f647
https://pure.eur.nl/en/publications/4faa317f-96fd-474a-96a6-4ba1a5a8f647
Autor:
Terpstra, WE, Leenen, Pieter, van den Bos, C (Cor), Prins, A (Ad), Loenen, WAM, Verstegen, Monique, van Wyngaardt, S, van Rooijen, N, Wognum, AW (Albert), Wagemaker, Gerard, Wielenga, JJ (Jenne), Löwenberg, Bob
Publikováno v:
Leukemia, 1049-1054. Nature Publishing Group
ISSUE=11;STARTPAGE=1049;ENDPAGE=1054;ISSN=0887-6924;TITLE=Leukemia
ISSUE=11;STARTPAGE=1049;ENDPAGE=1054;ISSN=0887-6924;TITLE=Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::731400d59975872b15520ceb710276ff
https://pure.eur.nl/en/publications/a505f8eb-0270-496c-8452-63214b11f8a7
https://pure.eur.nl/en/publications/a505f8eb-0270-496c-8452-63214b11f8a7
Publikováno v:
Leukemia, 10(1), 43-47. Nature Publishing Group
Patients with AML who relapse after an initial remission, have a poor prognosis. Administration of hemopoietic growth factors (HGFs) such as interleukin-3 (IL-3) during chemotherapy may result in an increased cell kill by cytotoxic agents. In additio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::98f644e7f951e6d2ea90833a4e5eb745
https://research.rug.nl/en/publications/e13a17ce-6c20-404f-a5b8-01268894124b
https://research.rug.nl/en/publications/e13a17ce-6c20-404f-a5b8-01268894124b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Terpstra, W, Ploemacher, RE, Prins, A, van Lom, K, Pouwels, K, Wognum, AW, Wagemaker, G, Lowenberg, B, Wielenga, JJ
Publikováno v:
Blood; September 1996, Vol. 88 Issue: 6 p1944-1950, 7p